ATCC provides trusted, cutting-edge models that empower breakthroughs in diagnostics development, drug discovery, and translational research.
Through targeted accessions and strategic partnerships, we deliver clinically relevant microorganisms and patient-derived cell lines that advance research in critical public health initiatives such as antimicrobial resistance, infectious disease, and cancer research. We also conduct our own internal research using the latest techniques and technologies to drive the development of innovative products with enhanced specificity and functionality. Explore our newest products below to discover how we can move your research forward.
Browse our featured portfolios
MicroQuant™
Streamline your microbial QC testing with best-in-class microbial controls provided in a single-use format that is precisely quantitated, rehydrates rapidly, and can be conveniently stored at 2-8°C.
HCMI Cancer Models
We are continually adding 2-D and 3-D patient-derived cancer models to our portfolio. These next-generation models include both common as well as rare and understudied examples of cancer from numerous tissues.